The College of Animal Welfare has opened a business school at its training and education centre in Chord Business Park in Godmanchester.
CAW Business School provides accountancy courses accredited by the Association of Accounting Technicians (AAT) and leadership and management courses accredited by the Institute of Leadership and Management (ILM).
Leslie Heaton Smith, Director at The College of Animal Welfare, said: "The opening of our Business School is a new development in a long line of achievements and marks an exciting new venture. Whilst our focus has always been towards developing technical animal and veterinary related knowledge and skills to make significant improvements in animal welfare and veterinary care, we also recognise that quality of care is also highly dependent on the management and leadership of those controlling and investing the organisation's often scarce resources. Thus in order to provide high quality welfare to animals entrusted into their care, organisations need to be able to employ people with such skills".
The leadership and management courses are already underway and can be studied entirely online, or online with study weekends.
The College says the majority of AAT courses will start in September 2013, however an 8 week Level 2 Certificate in Bookkeeping course starts at the beginning of June. The College is also an AAT approved exam centre, meaning that students can sit their exams whilst at college.
For further information, call the College on 01480 422060 and speak to one of the Business School tutors. Alternatively, visit www.caw.ac.uk or book a place on the next open day on Wednesday 22 May from 9am-12pm or 6-9pm.
The RCVS Disciplinary Committee has struck off a Wiltshire-based veterinary surgeon for charges relating to tuberculin (TB) testing on cattle that he undertook and certified at four farms during June and July of 2010.
At the end of the ten-day hearing, the Disciplinary Committee found Sorin Dinu Chelemen guilty of 32 charges relating to his work as an Official Veterinarian (OV) for Animal Health, while employed as a locum at Endell Veterinary Group, Salisbury. Mr Chelemen, who represented himself at the hearing, disputed all of the charges. He also said he had had poor knowledge and comprehension of written and spoken English at the time, which had since improved.
Mr Chelemen gave the Committee detailed accounts of what he said occurred in relation to the TB testing at all four farms. However, in almost all the points where the facts were denied, the Committee found a stark divergence between his evidence and that given by witnesses for the College.
The Committee was generally unimpressed by Mr Chelemen's account of events, finding many of his allegations and explanations for his actions to be incredible or unreliable. For example, he claimed that during his Animal Health training, he had not been given a copy of the 'Manual of Procedures' containing Standard Operating Procedures (SOPs) for TB testing. Although the Committee accepted Mr Chelemen's English had been poor at the time, leading to communication problems, he had satisfactorily demonstrated that he knew how to perform TB tests in accordance with these SOPs when he started work at the practice. Overall, the Committee found Mr Chelemen's attitude was that he had not done anything wrong and nothing was his fault, and that he had little understanding of the professional responsibilities incumbent on an OV.
By contrast, the Committee considered all the witnesses called by the College to have given clear, credible and consistent evidence. Complaints had been made about three farms that were separate and unconnected, and where the tests had been conducted on different dates. These complaints, if not identical, were very similar. The evidence was overwhelming that Mr Chelemen had not followed the SOPs when carrying out testing at three of the farms.
The Committee noted that the measurements recorded by Mr Chelemen did not show the differences which would be normally expected. Mr Chelemen had not measured the animals in accordance with the SOPs when he knew he ought to have, and he had been dishonest in certifying the tests.
When considering sanctions, the Committee found an aggravating factor was that Mr Chelemen's actions undermined procedures to prevent the spread of disease. In particular, he failed to notify the owners of animals on three farms that he had found reactors or inconclusive reactors, resulting in those animals not being isolated. Nor did he submit paperwork to Animal Health about these animals, which was a fundamental breach of his duties as an OV.
In mitigation, the Committee accepted that Mr Chelemen had no previous RCVS disciplinary findings against him; and, that the OV training he received was limited, having regard to English not being his first language and relative inexperience as a TB tester. It also took into account that this disciplinary case had been in progress for three years, his poor health and his financial and family circumstances.
Mrs Judith Webb, chairing and speaking on behalf of the Committee said: "The Committee is of the view that this is a most serious case, in which the integrity of TB testing was undermined, and animal health was put at risk, which may have resulted in the spread of disease. Furthermore, this case involves findings of dishonesty, which has been held to come at the top end of the spectrum of gravity of disgraceful conduct in a professional respect."
She directed that Mr Chelemen be struck off the Register.
Bayer Animal Health, maker of Tracer microchips, has produced a new video in which Emma Milne and Petlog Executive Celia Walsom consider the implications for practices of the change in the law which will make it compulsory for all dogs to be microchipped from April 2016.
The 15-minute video considers various issues, such as:
Richard Hepburn MRCVS has launched what is thought to be the world's first equine gastric ulcer study, designed to improve understanding and knowledge of ulceration in performance horses.
Mr Hepburn is conducting the InnerVision study of performance horses, which is being championed by the University of Liverpool, as part of his PhD.
21 appointed practices across the UK are participating in the study, and with each practice scoping between 10 and 20 animals, it will include well over 200 performance horses. Mr Hepburn said: "Gastric ulceration in sports horses is poorly understood, especially compared with racehorses. But what we do know is that it's a very important factor in the performance and well-being of many horses in training and competition."
2012 Paralympic Gold medallist Deb Criddle MBE also attended the launch event. She explained the difference that regular gastroscopy and ulcer management of Paralympic team horses had made to her success. Speaking about her Beijing ride, Pavaroti, she said: "If it weren't for the diagnosis and treatment of Pavaroti's ulcers I don't know what we'd have done. I would probably have had to withdraw him from training, so it made the difference between our partnership continuing or not".
Mr Hepburn expects a prevalence of approximately 60% and, keen to increase understanding of glandular ulceration, participants are being tasked to scope all areas of the stomach, pylorus and duodenum to ensure that every incidence of ulceration is diagnosed and recorded.
He says he is particularly eager to find out more about glandular disease, which hitherto has had little research: "Glandular disease appears to have a very different aetiology to squamous ulceration, and often presents with different signs. We also believe that prevalence of glandular ulceration is most common in sports horses."
"We hope that publication of this study will help all equine vets in their work with performance horses and the quest to prevent and manage equine ulcers," he added.
Merial is supporting the study with management assistance.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
The RCVS has announced the results of the 2013 Council and Veterinary Nurses Council elections.
4,661 veterinary surgeons voted, the highest turnout seen in ten years. 1,329 veterinary nurses voted, the highest ever number.
Veterinary surgeons voted incumbents Christopher Gray, Peter Jinman, Bradley Viner, Christopher Tufnell, and Jeremy Davies back onto the RCVS Council. However, the highest number of votes was given to Thomas Witte, who will be new to Council when he takes his seat in July. Veterinary nurses voted similarly by returning Andrea Jeffery to VN Council, whilst giving to Amy Robinson, another newcomer, the largest number of votes.
According to the College, turnout in both elections has increased markedly on last year in both absolute and proportional terms. Votes were cast by 4,661 veterinary surgeons (18.8%) and 1,329 veterinary nurses (12.5%), compared to 3,625 (15.1%) and 743 (7.5%), respectively, in 2012.
Gordon Hockey, RCVS Registrar said: "We're delighted with the increase in turnout. It's difficult to pinpoint the reasons for the increase, but hopefully, it's because increasing numbers of vets and nurses are feeling more engaged with the College. We have also undertaken extra communications activities this year, such as the 'hustings', which we hope have helped."
The Council election 'hustings' was a new venture this year, with RCVS Council candidates able to select three questions, submitted by voters, to answer in a live webinar run by The Webinar Vet.
Veterinary surgeons and VNs could cast their votes by post, online, or by text. The majority of vets voting chose to cast postal votes (3,247), as did the majority of VNs (1,055). Whilst voting online was used by 1,330 veterinary surgeons, only 227 VNs chose it as a means of voting. Voting by text was used by only 84 veterinary surgeons and 47 VNs.
The successful candidates will take up or resume their seats at RCVS Day on 5 July.
The full results of the two elections are as follows:
RCVS Council electionWITTE, Thomas Hermann - 2,251 (Elected)GRAY, Christopher John - 1,974 (Elected)JINMAN, Peter Charles - 1,949 (Elected)VINER, Bradley Phillip - 1,927 (Elected)TUFNELL, Christopher Wynne - 1,883 (Elected)DAVIES, Jeremy Vincent - 1,830 (Elected)STURGESS, Christopher Paul - 1,809 CONNELL, Niall Thomas - 1,596 ROBINSON, Peter Bayley - 1,366 ELLIS, Robert Nigel Ward - 1,302 GRANT, Lewis George - 832 TORGERSON, Paul Robert - 824 LONSDALE, Thomas - 337 Twenty-two votes in the RCVS Council election were found to be invalid.VN Council election
ROBINSON, Amy - 725 (Elected)JEFFERY, Andrea Karen - 607 (Elected)BADGER, Susan Frances - 459TOTTEY, Helen Wendy 332 One vote in the VN Council election was found to be invalid.The 2013 RCVS and VN Council elections were run on behalf of the RCVS by Electoral Reform Services.
Petplan has announced the finalists for the inaugural Petplan and Association of Dogs and Cats Homes (ADCH) Animal Charity Awards.
The awards have been set up by Petplan to celebrate the outstanding work of animal charities and not-for-profit organisations across the UK.
The finalists for each of the categories are:
Animal Charity Team of the Year
Animal Charity Volunteer of the Year
Animal Charity Employee of the Year
Simon Masding, Petplan's Head of Sales and Partnerships said: "Animal wellbeing is central to all we do at Petplan. We work with over 1,500 animal charities and give over £2million to assist them every year. The Petplan and ADCH Animal Charity Awards is another way for us to support and recognise the teams and individuals at charities dedicated to improving the lives of animals. We're delighted that these new awards have got off to a fantastic start with over 3,400 nominations from adopters, supporters, charity staff and volunteers."
Winners will be announced on the 2nd May in an awards ceremony in Stratford-upon-Avon. For further information go to www.petplan.co.uk/charityawards
Bayer Animal Health has announced the launch of a new campaign which plays on our anthropomorphic nature to drive owners into practice for worming.
As part of the campaign, the company has enrolled the behaviour specialist and author Sarah Whitehead to oversee a video analysis of the behavioural interaction between a small number of dogs and their owners. The results will be used to make an educational film for pet owners which helps them better understand their pet's emotions and behaviour.
Tracey Dawson, Group Product Manager at Bayer Animal Health said: "We want owners to really understand the importance of health on their dog's happiness and behaviour, whilst reminding them to worm their pet at least four times a year. Our ground breaking research will make owners feel like real-life Dr Doolittle, as they will better understand their pet's emotions and actions, highlighting the importance of keeping their dogs healthy, happy and worm-free."
In order to prompt owners to worm their dog more frequently, Bayer has also launched a free SMS/email worming reminder service available at www.drontal.com. In addition, there'll be a new CPD section for SQPs on the website in the summer..
Bayer is also developing 'Worm Reminder' toolkits for veterinary practices, including a press release template, infographics, and video report of the research findings to further promote the importance of worming frequently. For more information, talk to your Bayer representative.
To what extent changing diets and adding novel feed additives can cut emissions from beef cattle is being investigated in a new three-year research project.
EBLEX, the organisation for beef and sheep producers in England, has teamed up with Scotland's Rural College, SRUC, in Edinburgh, to look at how changes to feeding regimes can improve efficiency and drive business profitability, while reducing greenhouse gas (GHG) emissions produced as a by-product of rumination.
Steers will be finished on either concentrate based or forage based diets, each with two different feed additives, such as vegetable oils. The role of the rumen microbial population in the responses will be measured to look at how rumen function changes according to diet, additive and breed. Results will be related to the greenhouse gas emissions and feed efficiency, as well as long-term effects of feed additives.
Dr Mary Vickers, senior livestock scientist with EBLEX said: "The animals will be moved into specialist chambers for short periods of time where their emissions can be captured.
"In addition, when they are accessing rations from group pens, special plastic hoods over the feeding stations can measure the specific emissions at those times. Measuring emissions, rumen function, feed intake and growth rates can help us build a picture of any effect the additives have.
"The ultimate aim is to ensure the cattle are having their full nutritional needs met in an efficient, cost effective way while minimising the emissions produced."
In addition, carcase quality, meat quality and shelf life will also be recorded to ensure quality of the final product is maintained. The outcomes of this project will provide producers with independent advice about the efficacy of two feed additives fed in a range of commercial conditions.
Novartis Animal Health has announced the launch of a new campaign called Prepare, Predict, Prevent and designed to raise awareness of blowfly strike management in sheep.
The campaign will include new industry research, an expert-led report, and information tailored to farmers, veterinary surgeons and SQPs. The campaign is aimed at improving awareness of blowfly strike management, with a particular focus on prevention.
In the UK, blowfly strike (myiasis) occurs on over 80 per cent of sheep farms2. If untreated, strike can severely affect the welfare of infested sheep, and may result in death. For farmers, poor management of blowfly strike brings economic costs in terms of the loss of animal, production losses and in terms of treatment and control of the disease, which is easily spread.
Furthermore, previous research from the University of Bristol4, which simulated the pattern of parasite growth in different climate-dependent environments, showed that an increase in average temperature of 3 degrees Celsius would be enough to quadruple the incidence of strike in ewes and double the rate in lambs. This is a growing concern, with climate change models for the UK suggesting that over the next 50 years summer temperatures are set to increase by 1.5 degrees Celsius and winter temperatures by 2.5 degrees Celsius5.
Research conducted at the 2013 Animal Health Distributors Association (AHDA) Annual Conference indicated that, in the past five years, many believe the blowfly strike season is lasting longer and beginning earlier in the year, with the majority of early reported cases occurring unexpectedly in March. The findings have prompted a wider survey from Novartis Animal Health, which is urging SQPs, farmers and key opinion leaders nationwide to contribute answers at: www.farmanimalhealth.co.uk/fleecebind-questionnaire.
Katherine Openshaw, Ectoparasiticides Category Manager at Novartis Animal Health, said: "This has always been a serious issue for the sheep industry and elevated temperature is likely to bring about increased levels of blowfly strike and a longer season.
"We recognise the need to evolve attitudes towards parasite control and to provide farmers and prescribers with the knowledge and tools needed to facilitate a better management of blowfly strike. The 'Prepare, Predict, Prevent' campaign is all about simple, yet effective, measures to prevent the occurrence of blowfly strike, which can be enough to ensure farmers are protected from the potentially devastating impacts of flock infestation, offering season peace of mind.
"We have developed a range of materials to aid prescribers in promoting preventative solutions to farmers; these include farmer leaflets, posters and counter displays. We will also be offering training support so prescribers are best equipped to help farmers make informed decisions about preventative blowfly solutions."
References
Invicta Animal Health has launched EthyCalm Spray, a cryoanalgesic for minor procedures.
The active ingredient, ethyl chloride, acts as a local analgesic (pain relief) when sprayed or wiped onto the skin.
According to the company, the product is effective in a few seconds and works for a few minutes until the skin warms up again. This makes it suitable for such things as venepuncture, tick removal or placing of PVC's, where it should help reduce stress for the patient and the practitioner.
Ethycalm is presented in a 50ml vial which provides up to 100 applications.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to launch EthyCalm. During theatre training sessions for our product, ChloraPrep, we realised that the busy nurse doesn't have time to use traditional analgesia methods such as creams. They needed something instant yet cost-effective. Seeing the widespread use of ethyl chloride in places like Great Ormond Street Hospital, it was obvious that this product needed to be made available to veterinary practices".
For further information see www.invictavet.com or phone 01403 791313
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
Owners of hyperthyroid cats say they would rather veterinary surgeons prescribed the appropriate dosage for their pets than have an easy way to administer the medicine, according to new research carried out by feline expert Dr Sarah Caney BVSc PhD DSAM (Feline) MRCVS.
111 cat owners were questioned for the research, which was supported by Dechra Veterinary Products and has been accepted for publication in the Journal of Feline Medicine and Surgery.
Dechra says the results of the study challenge long-held perceptions, and should encourage a reappraisal of the approach to oral anti-thyroid medication:
89% of cat owners agreed with the statement that it 'was more important to me that the vet prescribes the most appropriate dose for my cat than that they provide me with an easy method of administering the medicine.'
Dr Caney said: "The survey has shown that cat owners are not a barrier to prescribing twice daily medication. Their overwhelming drive is to provide the best level of care that they can.
"From an owner perspective, the ideal anti-thyroid medication offers low doses and a variety of dosing strategies to ensure that each individual cat receives the dose they need and no more."
The findings revealed that 'once daily treatment' was not ranked as the most important statement on dosing by any of the owners and that only 21% of owners who had experienced oral dosing of their cat described the process as either 'tricky' or 'very difficult'.
Craig Sankey, Brand Manager for Felimazole at Dechra Veterinary Products, said: "We are very pleased to have supported such an important piece of independent research relating to feline hyperthyroidism which challenges some of the assumptions made about owner needs.
"Ease of administering the medicine is not the overwhelming issue for owners of cats with hyperthyroidism - administering the correct dose is. In fact, 79 % of cat owners questioned were happy to give pills twice a day if necessary."
To see the latest research in full, please visit www.dechra.co.uk/hyperthyroidism
The WSAVA's Global Nutrition Committee (GNC) has launched a Nutrition Toolkit for veterinary professionals.
The non-branded toolkit contains the following materials:
The toolkit is available for download at http://wsava.org/nutrition-toolkit.
Based on its importance to overall health, the WSAVA is campaigning to have a nutritional assessment confirmed as the fifth vital assessment in a standard physical examination and for the veterinary healthcare team to provide nutritional recommendations for each animal as an integral component of patient care.
The launch of the Nutrition Toolkit follows on from the Global Nutrition Committee's first initiative, the creation of a set of Nutrition Guidelines in 2011. These were aimed at helping veterinary professionals and pet owners ensure that pets are fed according to an optimal and individually tailored nutrition plan. According to WSAVA, they have been successful, securing endorsements from 19 veterinary organizations in 16 countries. They have been translated into ten languages and are available for download at http://www.wsava.org/guidelines/global-nutrition-guidelines.
GNC Co-Chair Dr Marge Chandler said: "Research shows that more than 90% of pet owners would like nutritional advice but fewer than 15% feel they receive it. In some parts of the world, pet malnutrition remains a major challenge, while in many other countries, pet obesity is an increasing problem. In addition, there is confusion about optimal nutrition because there is now so much conflicting and inaccurate information available online.
Our Nutrition Toolkit is designed to help the veterinary healthcare team address nutrition at every patient visit and to advance the central role of the veterinary healthcare team as the expert source of nutrition information."
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
The Born Free Foundation, British Veterinary Association, Captive Animals' Protection Society and the RSPCA have welcomed the Government's draft legislation to ban the use of wild animals in circuses in England, to be implemented in 2015.
The groups, which have worked closely together for a number of years on the campaign to seek an end to the use of wild animals in big tops in the UK said that they were "delighted" to see the ban brought forward in concrete terms.
A spokesperson, talking on behalf of all four leading organisations said: "We are pleased to see that the Government appear to have come good on their promise to ban the outdated practice of using wild animals in circuses.
"We have long argued that the complex needs of wild animals cannot be met in a travelling circus environment and were disappointed when the Government introduced a licensing regime earlier this year which appeared to legitimise a practice which we, and our hundreds of thousands of supporters, want to see abolished altogether.
"We are looking forward to seeing the ban fully implemented at the earliest opportunity".
BVA President Peter Jones said: "Whilst there are only 20 wild animals kept by two licensed circuses in the UK, their welfare is emblematic of the way we treat all animals."
The groups said that they would work to support Government in the formal enactment of the Bill and the Born Free Foundation and the RSPCA reiterated their pledge to offer to find safe homes for life for all wild animals currently being used in English circuses.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
The Royal College is inviting veterinary surgeons to the first-ever Virtual Question Time, which is being held online with The Webinar Vet, from 8-9.30pm on Wednesday 24 April.
Lizzie Lockett, Head of the RCVS Communications Department said: "This is an ideal opportunity to put your burning questions to members of the RCVS Officer team and to VN Council. Our regular Question Time meetings are popular, so we are following their format by asking delegates to set the agenda via their choice of questions. This time there is the extra advantage that busy vets and nurses can take part from the comfort of their own homes. If the Virtual Question Time proves successful, we may hold these events regularly."
The meeting will be run as a free, live-audio webinar. RCVS President Jacqui Molyneux will open proceedings, and introduce the panel, before answering questions from the participants.
Questions may be put to the College in advance and can also be submitted as discussion unfolds on the night. These can be on any issues affecting the veterinary and veterinary nursing professions - there is no set agenda - and might range from the First Rate Regulator initiative, new vet schools, veterinary nurse training and clinical governance, to proposed changes to the Practice Standards Scheme and recent amendments to the Veterinary Surgeons Act.
The session will also be recorded so those unable to attend on the night can still listen afterwards.
The meeting can be counted towards continuing professional development for veterinary surgeons and veterinary nurses. Registrations and questions can be submitted online at http://thewebinarvet.com/rcvs/#.
Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland.
Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of presentations for dogs, cats, and horses.
The product, which was previously marketed by MSD, is the leading joint health supplement among veterinary surgeons in the US and Europe.
Novartis says Cosequin is an important addition to its Orthopaedic Health Category, which in 2009 introduced Onsior (robenacoxib), the first tissue-selective pain relief for cats and dogs.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "Our strategic intent is to expand our presence in orthopaedic health to address prevention, diagnosis, and treatment in a more comprehensive manner. Cosequin represents an important step toward achieving this objective".
Cosequin is available from Novartis Animal Health in the United Kingdom and Ireland, from licensed veterinary wholesalers. For more information on Cosequin, contact your Novartis Animal Health Territory Manager.
The RCVS Disciplinary Committee has dismissed a case against a veterinary surgeon said to have been dishonest in claims made against insurance following a dog's veterinary treatment.
At the end of the four-day hearing, the Committee found Sheena Brimelow, formerly employed by Kinver Veterinary Practice in Kinver, Stourbridge, not guilty of charges relating to seven insurance claims submitted between 1 January 2008 and 1 October 2009. These related to her parent's dog, a Cairn terrier, which she had treated at her then employer's practice. Ms Brimelow admitted that she had submitted invoices with her claims showing the retail prices for several items, when she had paid the practice only the cost prices. She said that she had deleted records from the practice computer showing the retail prices so that the ingoings and outgoings in the practice finances were accurate.
The Committee considered whether Ms Brimelow had either behaved dishonestly or, in the alternative, ought to have known not to have included the sums she did in the insurance claims forms. The Committee found that Ms Brimelow was an honest and reliable witness. She had explained openly what she had done, entirely consistently, from the first time the allegations had been put to her by the practice owner. It noted that an insurance company representative also considered her actions to be "a genuine misunderstanding," although subsequently a complaint was made by the insurance company to the College about Ms Brimelow's actions. The Committee found there were no clear guidelines in the practice as to how staff insurance claims should be handled. It also felt that, as a result of the insurer's communications failures, it was not difficult to believe that Ms Brimelow was unaware of how claims concerning the insured pets of veterinary practice staff members were expected to be handled.
From the evidence presented in the hearing, the Committee calculated that Ms Brimelow had benefited by only £90.50. The Committee noted that she had offered to repay any monies to her employer or the insurer, and that the insurer's loss adjusters had thought this was a matter for Ms Brimelow and her employer. The College had also referred the matter to the police, who said it was not in the public interest to proceed with the matter, a decision they based on the low value of the loss and Ms Brimelow's offer to pay back the money.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "The Committee notes the reasons given by the police for undertaking no criminal investigation in this case, and agrees with that analysis. The Committee must apply the same standard of proof as would have been applied in a criminal case. In all the circumstances, the Committee is far short of being satisfied so that it is sure that Ms Brimelow acted dishonestly in this case."
"The Committee considers that [Ms Brimelow] was naïve and misguided in handling the insurance claims in the way that she did," he continued. "However, the Committee considers there was a lack of proper guidance within the practice as to how staff insurance claims should be handled. In these circumstances the Committee is not sure that the College has proved that the Respondent ought to have known that she should not have included sums on the claims form, which did not represent the costs that she had incurred."
Both elements of the charge were accordingly dismissed.
Jon Bowen, animal behaviour consultant at the Royal Veterinary College and Sureflap have declared 8th May 'Vet Cat Watch Day', and are asking the profession to record the reason why each cat seen that day is brought into the practice.
Jon explained: "There are more than 10 million pet cats in the UK, however there is little information about the prevalence of injuries, disease, cat fights and road traffic accidents on a national scale".
The absence of data became apparent when findings from research on over 1,000 cats - conducted as part of the Neighbourhood Cat Campaign, supported by SureFlap and Your Cat magazine - revealed cats that had suffered minor injuries from fights were more likely to develop other health issues, such as hair loss and eye infections.
Judith Bank from SureFlap said: "People often purchase a microchip-operated cat flap to help their pet to feel secure. Owners tell us that their pet is spraying in the house or has been losing fur and this motivated us to support research to look deeper into the problems that pet owners might be having. We soon realised that objective data from vets was not available to qualify the findings and this is where the idea of 'Vet Cat Watch Day' emerged."
Jon said: "The aim of Vet Cat Watch Day is to take a snap-shot of cats' health from veterinary practices across the nation, on one day. The results will be compiled alongside information from cat owners gained in 'Cat Watch Day' a few days earlier.
A report detailing preliminary findings from the Neighbourhood Cat Campaign is available from the SureFlap website. When complete the results will be used to help provide vets with an insight into the lives of domestic cats so they are better equipped to understand behavioural issues.
For more information on Vet Cat Watch Day please visit the SureFlap website The site hosts a PDF to print out and help record the feline cases that come through practice doors on the 8th May, which can be downloaded from www.sureflap.co.uk/vetwatch_info. At the end of the day, visit www.sureflap.co.uk/vetwatch to upload your data to the online survey.
Six individuals have been announced as the winners of the second annual Ceva Animal Welfare Awards, honoured for their contributions to the prevention and reduction of animal welfare problems in the UK and abroad.
All winners were originally nominated by friends, colleagues or family. The judging panel consisted of panel chairman and veterinary surgeon Chris Laurence MBE, Ross Tiffin of the International Cat Care (formerly the Feline Advisory Bureau), Dennis Baker, OBE, Chief Executive at Wood Green, the Animal Charity and media vet, Joe Inglis. Marc Abraham also assisted in the Volunteer categories.
Dr. Pascal Raoul, Ceva's Head of Global Pharmaceuticals, said: "Ceva is delighted to host these Animal Welfare Awards as they help to highlight the incredible affection and care that people have for animals. With 6 billion people living in megacities in the future, companion animals will often be their major link to nature. The benefits that animals have on improving human health are well documented; in turn we all have a duty to protect them and this evening we have seen some of the best examples, from professionals, members of the public, young and old as to how that should be done."
Timothy Phillips, a Plymouth-based vet from the Elm Veterinary Group (above right), was awarded the Chris Laurence Vet of the Year Award for his 15 years of charitable work in the Greek Islands with Friends of the Strays of Greece. Tim performs surgeries and other treatments, helping to establish a re-homing system, with dogs fully vaccinated and declared healthy by the vets before being flown out of Greece.
Veterinary Nurse Scott Parry of Bridge Veterinary Surgery was awarded Welfare Nurse of the Year for his work with the RSPCA's Brent Knoll Animal Centre. Scott has spent hours of his own time raising funds and helping with the rehabilitation of a number of traumatised dogs. He also recently assisted in an RSPCA visit to a travellers' camp to vaccinate more than 50 dogs following an outbreak of Parvo Virus on the site.
Other award winners included Logan McKerron, aged 6, who was awarded Young Person of the Year for his fundraising for Hearing Dogs for Deaf People; Kim Taylor, co-founder of the charity Animal Care Egypt, was awarded the Charity Professional of the Year accolade for her work setting up a large animal hospital helping more than 26,000 animals every year; Faye Stacey of People4Ponies in Devon was awarded the UK Volunteer of the Year Award for the large part she has played in stopping ear cutting, notching and tagging of equines in the UK; Jen White has been named International Volunteer of the Year for her work with the Gambia Horse and Donkey Trust.
The BSAVA reports the highest ever attendance at Congress this year: 6,178 veterinary surgeons, nurses, practice managers and students, 6% cent higher than in 2011 (the last time the BSAVA hosted its own Congress).
According to the association, a significant number of international delegates attended this year with almost 60 countries represented - notably Scandinavia (186 delegates), Germany (56), the Netherlands (40) and the USA (31).
Other highlights included:
Outgoing BSAVA president Mark Johnston said the event was the highlight of his presidential year: "Last year we showed the world how well the BSAVA can organise a major veterinary congress. But what is pleasing is that the momentum we gained from hosting the World and European meetings has continued into this year.
"We had more delegates in 2013 than in the last purely BSAVA Congress two years ago and to accomplish that in these difficult financial times is a remarkable achievement."
Newly inducted BSAVA president Michael Day (top right) said he was looking forward to extending the international aspect of BSAVA. The Australian-born Professor who has lived in the UK for well over two decades said: "BSAVA has made huge contributions to veterinary practice in the UK, and already has a global reputation for Congress and publications - I believe we have such a wealth of resources and so I am convinced we have so much more to offer the world".